Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
11.30
-0.11 (-0.92%)
Aug 6, 2026, 4:00 PM EDT - Market closed

Neogen Revenue

In the fiscal year ending May 31, 2026, Neogen had annual revenue of $870.40M, down -2.72%. Neogen had revenue of $225.30M in the quarter ending May 31, 2026, a decrease of -0.09%.

Revenue (ttm)
$870.40M
Revenue Growth
-2.72%
P/S Ratio
2.80
Revenue / Employee
$330,197
Employees
2,636
Market Cap
2.46B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
May 31, 2026870.40M-24.30M-2.72%
May 31, 2025894.70M-29.50M-3.19%
May 31, 2024924.20M101.75M12.37%
May 31, 2023822.45M295.29M56.01%
May 31, 2022527.16M58.70M12.53%
May 31, 2021468.46M50.29M12.03%
May 31, 2020418.17M3.98M0.96%
May 31, 2019414.19M16.26M4.09%
May 31, 2018397.93M39.65M11.07%
May 31, 2017358.28M37.00M11.52%
May 31, 2016321.28M38.20M13.50%
May 31, 2015283.07M35.67M14.42%
May 31, 2014247.41M39.88M19.22%
May 31, 2013207.53M23.48M12.76%
May 31, 2012184.05M11.36M6.58%
May 31, 2011172.68M32.17M22.90%
May 31, 2010140.51M21.79M18.35%
May 31, 2009118.72M16.30M15.92%
May 31, 2008102.42M16.28M18.90%
May 31, 200786.14M13.71M18.92%
May 31, 200672.43M9.68M15.42%
May 31, 200562.76M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Enovis2.30B
Haemonetics1.35B
Inspire Medical Systems898.74M
iRhythm Holdings787.85M
NovoCure699.19M
TransMedics Group668.47M
UFP Technologies631.64M
Axogen251.17M
Revenue Rankings